Immunosurveillance of senescent cells: the bright side of the senescence program
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Cellular senescence, a state of irreversible cell cycle arrest, is a robust mechanism used to mediate tumor suppression and control the tissue damage response following short-term insults. In addition, the senescence associated-secretory phenotype (SASP), one of the most profound characteristics of the senescence program, facilitates the immunosurveillance of senescent cells. The SASP includes many chemokines, cytokines and adhesion molecules that can recruit and activate distinct immune cells from both the innate and adaptive immune system such as NK cells, monocytes/macrophages and T cells. Furthermore, senescent cells can upregulate specific immune ligands on their cell surface that can mediate the recognition of these cells by specific immune cell subsets and lead to activation of the immune cells. Consequently, the activated immune cells engage explicit regulatory mechanisms to eliminate senescent cells. For example, recent work from our laboratory showed that perforin-granzyme exocytosis mediates NK-cell killing of senescent cells. Here, we summarize the current advances in our knowledge of the mechanisms underlying specific immune-mediated elimination of senescent cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Senescence immunosurveillance is also essential to limit pathological fibrotic conditions and ageing20,145,151,157.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [151]
In the citing paper
“The homeostatic function of senescent cells is dependent on their elimination by the immune system, once their beneficial functions have been performed145,151.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [151]
In the citing paper
“Specialized SASP chemokines are able to attract distinct subsets of immune cells, including NK cells, neutrophils, dendritic cells, monocytes/macrophages, B cells and T cells75,151,152.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [151]
In the citing paper
“Senescent cells are indeed subjected to immunosurveillance by multiple components of innate and adaptive immunity, including NK cells, T cells and macrophages145,151,153–156.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [151]
In the citing paper
“NK cells use perforin-mediated granule exocytosis and not death receptor ligands, which induce cell death by binding to these receptors, to target senescent cells151.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [151]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 2×
“(Hayflick and Moorhead 1961), today the senescence program is widely appreciated for its myriad biological functions in vivo (Campisi 2013).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“…characteristics of senescent cells includes elevated levels of senescenceassociated b-galactosidase activity owing to increased lysosomal mass (Dimri et al. 1995), enlarged cell morphology, DNA damage foci and DNA damage signaling, elevated autophagy and a highly proinflammatory secretory…”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Consequently, when stimulated by distinct cytokines, macrophages adopt context dependent phenotypes that either promote or inhibit host anti-microbial defense, anti-tumor immunity and inflammatory responses (Gordon and Taylor 2005; Murray and Wynn 2011; Sica and Mantovani 2012).”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 5×
“Thus, in steady state and in response to inflammation the primary role of monocytes is to replenish the pool of tissue-resident macrophages and DCs, a process in which the cytokine milieu is crucial (Murray and Wynn 2011).”
BackgroundInfluentialThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 4×
“This proinflammatory signature of the SASP can have deleterious effects such as promoting damage to neighboring cells, facilitating tumor aggressiveness and modulating the tissue microenvironment (Coppe et al. 2010).”
BackgroundInfluentialMonocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 8×
“For example, in mice the recruitment of ‘patrolling monocytes’ to atherosclerotic plaques was shown to be partially dependent on CCR5 (Gordon and Taylor 2005; Shi and Pamer 2011).”
BackgroundInfluentialCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Recently, a seminal study by Baker et al. 2011 directly demonstrated the role of senescent cells in driving agedrelated pathologies by generating a transgenic mouse model, in which p16 INK4a -expressing cells can be specifically eliminated.”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 4×
“time of CD4 T cell activation can further influence and sustain the differentiation of CD4 T helper cells into Th1, Th2, Th17 and Treg subsets based on production of signature cytokines (Zhu et al. 2010).”
BackgroundInfluentialMonocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015 · cited 11×
“For example, in mice the recruitment of ‘patrolling monocytes’ to atherosclerotic plaques was shown to be partially dependent on CCR5 (Gordon and Taylor 2005; Shi and Pamer 2011).”
BackgroundInfluentialAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“(Hayflick and Moorhead 1961), today the senescence program is widely appreciated for its myriad biological functions in vivo (Campisi 2013).”
BackgroundInfluentialLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“Ligands of these receptors are upregulated in the different senescent tumor cells and in the senescent activated HSCs, and might provide the signal needed to activate NK cells for killing (Lanier 2005).”
BackgroundThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 10×
“For example, the SASP factors CTACK (CCL27), MCP-1 (CCL2), RANTES (CCL5), I-TAC (CXCL11), IL-1a and leptin have been associated with T cell adaptive immunity mobilization, activation and differentiation (Akdis et al. 2011; Bromley et al. 2008; La Cava and Matarese 2004).”
BackgroundInfluentialSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 15×
“(Xue et al. 2007) controls the production, differentiation and function of macrophages (Pixley and Stanley Biogerontology (2013) 14:617–628 623”
BackgroundInfluentialSelf-citationBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 4×
“…tumors and mouse models, is its ability to impose a potent barrier to tumorigenesis in response to various transforming stimuli such as activated oncogenes and DNA damage (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005; Schmitt et al. 2002; te Poele et al. 2002).”
BackgroundInfluentialThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 2×
“1995), enlarged cell morphology, DNA damage foci and DNA damage signaling, elevated autophagy and a highly proinflammatory secretory phenotype (Coppe et al. 2008; Freund et al. 2010; Kuilman et al. 2010; Young et al. 2009).”
BackgroundSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 25×
“In the presence of chronic liver damage, disruption of the p53-dependent senescence program in HSCs increases liver fibrosis and cirrhosis leading to reduced survival and enhanced transformation of adjacent epithelial cells (Lujambio et al. 2013).”
BackgroundInfluentialSelf-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 4×
“…tumors and mouse models, is its ability to impose a potent barrier to tumorigenesis in response to various transforming stimuli such as activated oncogenes and DNA damage (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005; Schmitt et al. 2002; te Poele et al. 2002).”
BackgroundInfluentialCellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 5×
“Accordingly, the senescence program activates the p53 and p16 INK4a -pRb tumor suppressor pathways which initiate and maintain the senescence growth arrest (Campisi and d'Adda di Fagagna 2007; Collado et al. 2007).”
BackgroundInfluentialSenescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621 · cited 14×
“T cell knockout mice, immune clearance of mutant NrasG12V-expressing precancerous senescent hepatocytes was abolished (Kang et al. 2011).”
BackgroundInfluentialCytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets
O'Garra, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80533-6 · Cited by 1,533 · cited 1×
“For example, in the case of the Th1/Th2 dichotomy, the characteristic cytokines are: IFN-c for a Th1 response as opposed to IL-4 and IL-5 for a Th2 response (O’Garra 1998).”
BackgroundSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 6×
“Indeed, over the past decade mounting data have shown that cellular senescence prevents tumorigenesis (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005), limits short-term tissue damage (Fitzner et al.”
BackgroundInfluentialT-Cell Function and Migration — Two Sides of the Same Coin
von Andrian, U. H., & Mackay, C. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431407 · Cited by 1,437 · cited 1×
“Following specific antigen recognition, activated T cells rapidly proliferate, migrate through the tissues to the sites of antigen presence, and perform effector functions such as cell-mediated cytotoxicity and production of various cytokines (von Andrian and Mackay 2000).”
BackgroundInfluentialInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354 · cited 13×
“These chemokines are secreted by different types of senescent cells in various combinations, depending on cell context (Freund et al. 2010).”
BackgroundInfluentialBernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269 · cited 2×
“In addition, the macrophage migration inhibitory factor (MIF), also secreted as part of the SASP, can induce CXCR2mediated monocyte arrest at sites of inflammation (Bernhagen et al. 2007; Freund et al. 2010).”
BackgroundOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · cited 4×
“…tumors and mouse models, is its ability to impose a potent barrier to tumorigenesis in response to various transforming stimuli such as activated oncogenes and DNA damage (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005; Schmitt et al. 2002; te Poele et al. 2002).”
BackgroundInfluentialSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“Since its initial discovery, DCR2 has been widely used, along with other biomarkers, to characterize senescent cells in premalignant lesions albeit its functional role to the senescence program has been unknown (Collado et al. 2005; Collado and Serrano 2010).”
BackgroundStem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · cited 1×
“Namely, senescent cells have been associated with age-related limitations in tissue regeneration and stem-cell proliferative capacity (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundCellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101 · cited 1×
“Mounting data over the past decade have shown that senescent cells accumulate with age and drive agerelated diseases (Baker et al. 2011; Burton 2009; Herbig et al. 2006).”
BackgroundAutophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078 · cited 1×
“…b-galactosidase activity owing to increased lysosomal mass (Dimri et al. 1995), enlarged cell morphology, DNA damage foci and DNA damage signaling, elevated autophagy and a highly proinflammatory secretory phenotype (Coppe et al. 2008; Freund et al. 2010; Kuilman et al. 2010; Young et al. 2009).”
BackgroundA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · cited 2×
“…tumors and mouse models, is its ability to impose a potent barrier to tumorigenesis in response to various transforming stimuli such as activated oncogenes and DNA damage (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005; Schmitt et al. 2002; te Poele et al. 2002).”
BackgroundChien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046 · cited 2×
“Senescent cells upregulate the expression of the adhesion molecule ICAM-1 (Chien et al. 2011; Krizhanovsky et al. 2008; Xue et al. 2007), which binds to its receptor CD58 on NK cells.”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“Namely, senescent cells have been associated with age-related limitations in tissue regeneration and stem-cell proliferative capacity (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 3×
“2005), limits short-term tissue damage (Fitzner et al. 2012; Jun and Lau 2010; Krizhanovsky et al. 2008; Lujambio et al. 2013; Pitiyage et al. 2011), and promotes tissue aging and disease (Adams 2009; Burton 2009; Campisi 2013).”
BackgroundIncreasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 1×
“Namely, senescent cells have been associated with age-related limitations in tissue regeneration and stem-cell proliferative capacity (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundCytotoxic T lymphocytes: all roads lead to death
Barry, M., & Bleackley, R. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri819 · Cited by 933 · cited 2×
“Cytotoxic CD8 T cells are very effective in direct lysis of target cells bearing the antigen peptide in context of MHC class I (Barry and Bleackley 2002), while CD4 T helper cells produce cytokines that can be directly toxic to the target cells or can stimulate other T cell effector functions and B cell antibody produ…”
BackgroundThe weight of leptin in immunity
Cava, A. L., & Matarese, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1350 · Cited by 927 · cited 1×
“For example, the SASP factors CTACK (CCL27), MCP-1 (CCL2), RANTES (CCL5), I-TAC (CXCL11), IL-1a and leptin have been associated with T cell adaptive immunity mobilization, activation and differentiation (Akdis et al. 2011; Bromley et al. 2008; La Cava and Matarese 2004).”
BackgroundMonocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890 · cited 1×
“Collectively, owing to these trafficking capabilities monocytes have been implicated in many inflammatory diseases, including in sterile inflammation such as atherosclerosis (Woollard and Geissmann 2010).”
BackgroundChemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Johnstone, R. W., Frew, A. J., & Smyth, M. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2465 · Cited by 834 · cited 1×
“Consequent binding induces activation of caspase 8 in the target cells, which in turn activates the caspase cascade leading to their death (Johnstone et al. 2008).”
BackgroundCSF-1 regulation of the wandering macrophage: complexity in action
Pixley, F. J., & Stanley, E. R. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.016 · Cited by 807 · cited 1×
“Similarly, the M-CSF SASP cytokine (Xue et al. 2007) controls the production, differentiation and function of macrophages (Pixley and Stanley Biogerontology (2013) 14:617–628 623 2004).”
BackgroundInterleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778 · cited 1×
“For example, the SASP factors CTACK (CCL27), MCP-1 (CCL2), RANTES (CCL5), I-TAC (CXCL11), IL-1a and leptin have been associated with T cell adaptive immunity mobilization, activation and differentiation (Akdis et al. 2011; Bromley et al. 2008; La Cava and Matarese 2004).”
BackgroundNon-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766 · cited 9×
“In the presence of chronic liver damage, disruption of the p53-dependent senescence program in HSCs increases liver fibrosis and cirrhosis leading to reduced survival and enhanced transformation of adjacent epithelial cells (Lujambio et al. 2013).”
BackgroundInfluentialSelf-citationT-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720 · cited 4×
“Indeed, the combined actions of the Th1 cytokines, TNF and IFNc , directly induce senescence in b-cancer cells (Braumuller et al. 2013).”
BackgroundInfluentialTwo Sides of the Same Coin: Speech and Gesture Mutually Interact to Enhance Comprehension
Kelly, S. D., Özyürek, A., & Maris, E. (2010) · Psychological Science · doi:10.1177/0956797609357327 · Cited by 669
(2002) · PubMed · Cited by 640
Orchestrating the orchestrators: chemokines in control of T cell traffic
Bromley, S. K., Mempel, T. R., & Luster, A. D. (2008) · Nature Immunology · doi:10.1038/ni.f.213 · Cited by 593 · cited 11×
“For example, the SASP factors CTACK (CCL27), MCP-1 (CCL2), RANTES (CCL5), I-TAC (CXCL11), IL-1a and leptin have been associated with T cell adaptive immunity mobilization, activation and differentiation (Akdis et al. 2011; Bromley et al. 2008; La Cava and Matarese 2004).”
BackgroundInfluentialThe trafficking of natural killer cells
Grégoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E., & Walzer, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00563.x · Cited by 569
Human natural killer cell development and biology
Farag, S. S., & Caligiuri, M. A. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.10.001 · Cited by 506 · cited 4×
“The CD56 dim NK-cell subset has more potent cytotoxic activity whereas; the CD56 bright subset appear poised for cytokine secretion and can selectively traffic to the lymph nodes (LNs) (Farag and Caligiuri 2006; Gregoire et al. 2007).”
BackgroundInfluentialThe role of chemokines in linking innate and adaptive immunity
Luster, A. D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00308-9 · Cited by 474 · cited 1×
“Moreover, since innate immune signals play a critical role in initiating and instructing the development of adaptive effector mechanisms (Luster 2002), it is conceivable that immunosurveillance of senescent cells involves adaptive immunity components including T cell-mediated responses.”
BackgroundSoriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T., Guarini, A., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173914 · Cited by 460 · cited 4×
“…evidence suggests that recognition of senescent cells might rely on the NK-cell activating receptors NKG2D and DNAM1 (Krizhanovsky et al. Table 1 continued Italics represent chemokines that are not part of the SASP Biogerontology (2013) 14:617–628 621 2008; Soriani et al. 2009; Xue et al. 2007).”
BackgroundInfluentialG-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood
Semerad, C. L., Liu, F., Gregory, A. D., Stumpf, K., & Link, D. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00424-7 · Cited by 450 · cited 1×
“In addition, GM-CSF and G-CSF, two SASP cytokines, can stimulate the bone marrow to increase the production and output of monocytes (Semerad et al. 1999, 2002).”
BackgroundMonocyte trafficking in acute and chronic inflammation
Ingersoll, M. A., Platt, A. M., Potteaux, S., & Randolph, G. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.001 · Cited by 346 · cited 5×
“(CTL) CXCR2 CXCL8, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6 IL-8, GROa GROb, GROc, ENA-78, GCP- 2 - - ?”
BackgroundInfluentialRoberts, A. I., Lee, L., Schwarz, E., Groh, V., Spies, T., Ebert, E. C., & Jabri, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5527 · Cited by 335 · cited 1×
“In addition, IL-15, also secreted as part of the SASP, potentiates the NKG2D pathway through upregulation of NKG2D expression on NK cells (Krizhanovsky et al. 2008; Roberts et al. 2001; Xue et al. 2007).”
BackgroundHealing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326 · cited 2×
“2011), and promotes tissue aging and disease (Adams 2009; Burton 2009; Campisi 2013).”
BackgroundHazeldine, J., & Lord, J. M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.04.003 · Cited by 308 · cited 1×
“For example, the decline in NK-cell function in aged individuals have been associated with higher rates of infections and slower resolution of the inflammatory response (Hazeldine and Lord 2013).”
BackgroundCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 4×
“Other chemokines such as RANTES (CCL5), ENA-78 (CXCL5), GCP-2 (CXCL6), CTACK (CCL27), I-309 (CCL1), MCP-3 (CCL7) and MIP-1b (CCL4), are also secreted, depending on cell type, cellular context and senescence stimuli (Coppe et al. 2008; Freund et al. 2010).”
BackgroundInfluentialMechanisms of granule-dependent killing
Cullen, S. P., & Martin, S. J. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402244 · Cited by 285 · cited 2×
“cally blocked or disrupted by mutations (Cullen and Martin 2008).”
BackgroundSenescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases
Naylor, R. M., Baker, D. J., & van Deursen, J. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.193 · Cited by 280 · cited 1×
“For example, the SASP-mediated sterile inflammation has been shown to promote age-related pathologies such as cognitive impairment (Naylor et al. 2013).”
BackgroundRabin, R. L., Park, M. K., Liao, F., Swofford, R., Stephany, D., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3840 · Cited by 268 · cited 4×
“The SASP chemokines MCP-1 (CCL2), MCP-2 (CCL8), MCP-3 (CCL7), MIP-1a (CCL3), RANTES (CCL5), HCC-4 (CCL16), CTACK (CCL27), IL-8 (CXCL8), GCP-2 (CXCL6), and I-TAC (CXCL11) can also attract activated effector CD8 T cells due to their diverse pattern of homing receptor expression that include CCR1, CCR2, CCR5, CCR10, CXCR…”
BackgroundInfluentialGranule exocytosis mediates immune surveillance of senescent cells
Sagiv, A., Biran, A., Yon, M., Simon, J., Lowe, S. W., & Krizhanovsky, V (2013) · Oncogene · doi:10.1038/onc.2012.206 · Cited by 240 · cited 3×
“Our experiments showed that DCR2 is upregulated in both damage-induced senescent fibroblasts and senescent activated HSCs (Sagiv et al. 2013).”
BackgroundSelf-citationSchnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224 · cited 6×
“(CTL) CXCR2 CXCL8, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6 IL-8, GROa GROb, GROc, ENA-78, GCP- 2 - - ?”
BackgroundInfluentialDC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology
Geijtenbeek, T. B. H., Engering, A., & van Kooyk, Y. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.921 · Cited by 166 · cited 1×
“Macrophages are equipped with pattern recognition receptors, such as C type lectins which have been shown to bind specifically to ICAM-3, a known SASP factor (Freund et al. 2010; Geijtenbeek et al. 2002).”
BackgroundCellular senescence, ageing and disease
Burton, D. G. A. (2008) · AGE · doi:10.1007/s11357-008-9075-y · Cited by 160 · cited 3×
“2011), and promotes tissue aging and disease (Adams 2009; Burton 2009; Campisi 2013).”
BackgroundPerforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis
Yawalkar, N., Schmid, S., Braathen, L. R., & Pichler, W. J. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04222.x · Cited by 107 · cited 2×
“…role of the granule exocytosis holds true for other fibrosis-related pathological conditions such as lung fibrosis, atopic dermatitis and atherosclerosis, where granule exocytosis has also been implicated in disease pathology (Choy et al. 2003; Miyazaki et al. 2004; Yawalkar et al. 2001).”
BackgroundNKG2D and cytotoxic effector function in tumor immune surveillance
Hayakawa, Y., & Smyth, M. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.005 · Cited by 106 · cited 1×
“Interestingly, the combined action of NKG2D ligands and ICAM-1 on NK cells induces more efficient killing of target cells (Hayakawa and Smyth 2006).”
BackgroundPitiyage, G. N., Slijepcevic, P., Gabrani, A., Chianea, Y. G., Lim, K. P., Prime, S. S., Tilakaratne, W. M., Fortune, F., & Parkinson, E. K. (2011) · The Journal of Pathology · doi:10.1002/path.2839 · Cited by 101 · cited 4×
“Cells of the immune system such as NK cells, macrophages and T cells can eliminate senescent cells in multiple tissues (Fitzner et al. 2012; Kang et al. 2011; Krizhanovsky et al. 2008; Lujambio et al. 2013; Pitiyage et al. 2011; Xue et al. 2007).”
BackgroundInfluentialT-cell activation: a multidimensional signaling network
Tseng, S.-Y., & Dustin, M. L. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00370-8 · Cited by 97 · cited 1×
“The T cell-mediated immunity includes a primary response by naive T cells, effector functions by activated T cells, and persistence of antigen-specific memory T cells (Tseng and Dustin 2002).”
BackgroundChoy, J. C., McDonald, P. C., Suarez, A., Hung, V. H. Y., Wilson, J. E., McManus, B. M., & Granville, D. J. (2003) · Modern Pathology · doi:10.1097/01.mp.0000067424.12280.bc · Cited by 95 · cited 2×
“…role of the granule exocytosis holds true for other fibrosis-related pathological conditions such as lung fibrosis, atopic dermatitis and atherosclerosis, where granule exocytosis has also been implicated in disease pathology (Choy et al. 2003; Miyazaki et al. 2004; Yawalkar et al. 2001).”
BackgroundSemerad, C. L., Poursine-Laurent, J., Liu, F., & Link, D. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80090-4 · Cited by 87 · cited 1×
“In addition, GM-CSF and G-CSF, two SASP cytokines, can stimulate the bone marrow to increase the production and output of monocytes (Semerad et al. 1999, 2002).”
BackgroundSenescence determines the fate of activated rat pancreatic stellate cells
Fitzner, B., Müller, S., Walther, M., Fischer, M., Engelmann, R., Müller‐Hilke, B., Pützer, B. M., Kreutzer, M., Nizze, H., & Jaster, R. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01573.x · Cited by 66 · cited 5×
“2005), limits short-term tissue damage (Fitzner et al. 2012; Jun and Lau 2010; Krizhanovsky et al. 2008; Lujambio et al. 2013; Pitiyage et al. 2011), and promotes tissue aging and disease (Adams 2009; Burton 2009; Campisi 2013).”
BackgroundInfluentialThe perforin mediated apoptotic pathway in lung injury and fibrosis
Miyazaki, H., Kuwano, K., Yoshida, K., Maeyama, T., Yoshimi, M., Fujita, M., Hagimoto, N., Yoshida, R., & Nakanishi, Y. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015495 · Cited by 39 · cited 2×
“…role of the granule exocytosis holds true for other fibrosis-related pathological conditions such as lung fibrosis, atopic dermatitis and atherosclerosis, where granule exocytosis has also been implicated in disease pathology (Choy et al. 2003; Miyazaki et al. 2004; Yawalkar et al. 2001).”
BackgroundT-cell trafficking into sites of inflammation
Hamann, A. (2000) · British journal of rheumatology · doi:10.1093/rheumatology/39.7.696 · Cited by 22 · cited 3×
“…distinct subsets of NK cells, neutrophils, dendritic cells, monocytes/macrophages, B cells and T cells (Table 1, and Bromley et al. 2008; Charo and Ransohoff 2006; Gordon and Taylor 2005; Gregoire et al. 2007; Hamann and Syrbe 2000; Ingersoll et al. 2011; Murdoch and Finn 2000; Shi and Pamer 2011).”
Background
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Self-citationDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Self-citationCellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497
“Mechanisms of immune cell-mediated SC clearance are summarized in Table 2 and have recently been reviewed comprehensively [34,63].”
BackgroundOgrodnik, M., Evans, S. A., Fielder, E., Victorelli, S., Kruger, P., Salmonowicz, H., Weigand, B. M., Patel, A. D., Pirtskhalava, T., Inman, C. L., et al. (2021) · Aging Cell · doi:10.1111/acel.13296 · Cited by 405
“As the SASP has been shown to recruit immune cells, including T cells (Kang et al., 2011; Sagiv & Krizhanovsky, 2013), we hypothesized that targeting senescent cells could impact the number of infiltrating immune cells in the brains of aged mice.”
Background
Metadata
- Authors
- Sagiv, A., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Krizhanovsky, Valery
- ORCID
- Krizhanovsky, Valery
- Venue
- Biogerontology
- Published
- 2013-10-10
- Volume
- 14
- Issue
- 6
- Pages
- 617-628
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W2047119143
- Cited by
- 208
- References
- 73
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 16 · 2023: 19 · 2022: 20 · 2021: 16 · 2020: 21 · 2019: 20 · 2018: 16 · 2017: 13 · 2016: 16 · 2015: 9 · 2014: 7 · 2013: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- cellular senescence, immune surveillance, senescence-associated secretory phenotype, natural killer cells, macrophages, T cells, chemokines, cytokines, tumor suppression
- MeSH terms
- Age Factors, Aging, Animals, Humans, Killer Cells, Natural, Macrophages, Phenotype, Stem Cells, T-Lymphocytes, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.